Autism Spectrum Disorder - Early Signs, Diagnosis, Early Intervention, and the NDIS

Definition / Overview

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterised by persistent difficulties in social communication and interaction, together with restricted, repetitive patterns of behaviour, interests, or activities. The term "spectrum" reflects the wide range of presentations, severity levels, and functional abilities seen across individuals.

• Prevalence: Approximately 1 in 70 Australians; male-to-female ratio approximately 4:1, though females are increasingly recognised as under-diagnosed due to better social masking strategies.
• Age of recognition: Core features are typically present in early childhood; formal diagnosis commonly occurs between 2 and 5 years, though some individuals are diagnosed in adolescence or adulthood.
• Comorbidities are the rule, not the exception: intellectual disability (around 30-50%), ADHD, anxiety disorders, epilepsy, sleep disturbance, and gastrointestinal difficulties frequently co-occur.
• Prior diagnostic labels (autistic disorder, Asperger syndrome, PDD-NOS) have been unified under a single "ASD" diagnosis in current DSM-5 framing, with severity specifiers replacing discrete categories.

Pathophysiology / Aetiology

Genetic Basis

• ASD has a strong heritable component, concordance in identical twins is substantially higher than in fraternal twins.
• First-degree relatives of a child with ASD have a meaningfully elevated recurrence risk (~2-18% for siblings).
• Both common variants (many small-effect genes) and rare variants (copy number variants, de novo mutations) contribute.
• No single gene accounts for the majority of cases; ASD is genetically heterogeneous.

Neurobiological Mechanisms

• Early brain overgrowth has been observed in the first 1-2 years of life, associated with increased cortical surface area.
• Dysregulation of synaptic formation, pruning, and maintenance, pathways involving mTOR signalling have been implicated.
• Altered functional and structural connectivity, particularly in networks subserving social cognition (e.g. default mode network, social brain regions including the fusiform face area and superior temporal sulcus).
• Immune-CNS interactions, calcium signalling abnormalities, and disrupted cortical organisation are areas of active research.

Known Associations

• Genetic syndromes (Fragile X syndrome, tuberous sclerosis, Angelman syndrome) can present with ASD features, chromosomal microarray investigation is indicated at diagnosis.
• Fetal alcohol spectrum disorder can produce an ASD-like phenotype.
• Prematurity and intrauterine infections are associated risk factors.
• Vaccines do not cause ASD, the retracted study claiming a link has been thoroughly discredited. Students must be confident in countering this misconception.

Early Signs and Clinical Features

Red Flags by Age (Developmental Surveillance)

Early identification is critical because interventions are most effective when commenced before age 5, during maximal neuroplasticity. The following developmental red flags should prompt urgent referral, not a "wait and see" approach.

DSM-5 Core Features (Two Domains)

Domain A, Persistent social communication and interaction deficits (all three must be present):

1. Deficits in social-emotional reciprocity (e.g. failure of normal back-and-forth conversation, reduced sharing of interests, limited initiation of social interaction)
2. Deficits in nonverbal communication (e.g. poorly integrated eye contact, body language, gestures; limited facial expression)
3. Deficits in developing, maintaining, and understanding relationships (e.g. difficulty adjusting behaviour to social context, absence of interest in peers, absent imaginative play)

Domain B, Restricted, repetitive behaviours, interests, or activities (at least two must be present):

1. Stereotyped or repetitive motor movements, use of objects, or speech (e.g. lining up toys, echolalia, idiosyncratic phrases)
2. Insistence on sameness, inflexible adherence to routines, ritualised patterns
3. Highly restricted, fixated interests that are unusual in intensity or focus
4. Hyper- or hyporeactivity to sensory input (e.g. apparent indifference to pain, adverse response to specific textures or sounds, visual fascination with lights)

Additional DSM-5 requirements:

• Symptoms must be present from early development (though may not fully manifest until social demands exceed capacity)
• Symptoms cause clinically significant functional impairment
• Not better explained by intellectual disability alone or global developmental delay

Severity Specifiers

DSM-5 uses three severity levels based on the degree of support required in each domain:

Investigation and Diagnosis

Screening Tools (Primary Care Setting)

Early detection typically begins in primary care or maternal and child health settings. Screening tools include:

• Modified Checklist for Autism in Toddlers (M-CHAT): Validated for children 16-30 months; parent-completed questionnaire; high sensitivity in this age group; positive screens require follow-up interview.
• Social Communication Questionnaire (SCQ): Suitable for children ≥4 years with a mental age ≥2 years; completed by parents; based on symptom domains aligned with diagnostic criteria.
• Childhood Autism Rating Scale, 2nd Edition (CARS-2): Clinician-administered observation-based rating scale used across a wide age range.
• Ages & Stages Questionnaire (ASQ): Broader developmental surveillance tool used in well-child checks; not ASD-specific but flags developmental concerns.

Important: Screening tools identify children at risk, they do not make a diagnosis. A positive screen mandates referral for comprehensive assessment.

Gold-Standard Diagnostic Assessment

Diagnosis requires a multidisciplinary team assessment, typically involving a paediatrician or child psychiatrist, psychologist, and speech-language pathologist.

Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2):

• Considered the gold-standard observational assessment for ASD.
• Clinician-administered; involves structured and semi-structured social presses (activities and conversations designed to elicit social communication behaviours).
• Consists of five modules chosen based on language level and age, ranging from toddlers with no speech to verbally fluent adults.
• Generates a calibrated severity score that maps to DSM-5 severity levels.
• Provides structured observation of social reciprocity, communication, play, and restricted/repetitive behaviours.

Autism Diagnostic Interview, Revised (ADI-R):

• Semi-structured parent/caregiver interview covering developmental history, current behaviour, and early childhood behaviour.
• Particularly valuable for capturing developmental trajectory and early language milestones.
• Often used alongside ADOS-2 for comprehensive assessment.

Additional components of comprehensive assessment:

• Cognitive/intellectual assessment (to identify comorbid intellectual disability and document cognitive profile)
• Speech and language assessment
• Adaptive behaviour assessment (e.g. Vineland Adaptive Behavior Scales)
• Medical evaluation: hearing test (exclude hearing loss as a cause of communication delay), chromosomal microarray (recommended at diagnosis to identify genetic aetiology), EEG if epilepsy suspected, metabolic investigations if regression or clinical concern
• Behavioural and emotional assessment (screen for ADHD, anxiety, OCD)

Differential Diagnosis

Management and Early Intervention

Principles of Early Intervention

Early, intensive, evidence-based intervention commenced before age 5 is associated with substantially improved developmental outcomes across communication, adaptive behaviour, and cognitive domains. The primary goal is to build skills in communication, social interaction, play, and daily living, while supporting the family.

Evidence-Based Intervention Approaches

Naturalistic Developmental Behavioural Interventions (NDBIs):

• Current best-evidence approach combining behavioural learning principles with naturalistic, relationship-based strategies.
• Examples include the Early Start Denver Model (ESDM) and JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation).
• Delivered in natural environments (home, childcare); involves training caregivers as primary intervention agents.
• Intensity matters: at least 20-25 hours per week of structured intervention recommended for young children with significant impairment.

Applied Behaviour Analysis (ABA):

• Behavioural approach using reinforcement to build skills and reduce challenging behaviours.
• Discrete Trial Training (DTT) is one structured ABA format.
• Evidence supports ABA for skill acquisition; modern approaches emphasise child-led, naturalistic delivery rather than purely therapist-directed drills.

Speech and Language Therapy:

• Core component for all children with ASD.
• Targets not only expressive language but also pragmatic communication, augmentative and alternative communication (AAC) for non-verbal children.

Occupational Therapy:

• Addresses sensory processing difficulties, fine motor skills, self-care, and school readiness.

Specialised education supports:

• Inclusive education with specialist teacher aide support; some children access specialist autism-specific schooling.
• Social skills groups for school-aged children.

Medical Management of Comorbidities

Note: No medication treats the core features of ASD. All pharmacological management targets comorbid conditions.

The NDIS and Supporting Families

Role of the National Disability Insurance Scheme (NDIS)

The NDIS is an Australian Government scheme that provides individualised, needs-based funding for people with a permanent and significant disability, ASD is a recognised eligible condition.

• Access: Children are eligible from birth to age 65; ASD must be a permanent condition causing substantial functional impairment. Children with an ASD diagnosis from a recognised clinician typically meet eligibility criteria without requiring additional evidence of permanence.
• Early Childhood Approach (formerly ECEI): Children under 9 years (and their families) without a confirmed diagnosis can access early intervention supports while assessment is underway, diagnosis is not a prerequisite for initial support.
• Planning process: A participant plan is developed based on reasonable and necessary supports, encompassing capacity-building supports (therapies, early intervention programs), core supports (daily activities, equipment), and capital supports (assistive technology, home modifications).
• Registered providers: Families can choose registered or (in most circumstances) non-registered providers; supports include speech therapy, occupational therapy, psychology, behaviour support, and intervention programs.

How GPs and Junior Doctors Support NDIS Access

• Document functional impairment clearly in referral letters, specify how ASD affects daily activities, communication, and participation.
• Complete supporting evidence forms accurately; vague language delays access.
• Refer early: there is no advantage in delaying referral pending behavioural settling.
• Signpost families to the NDIS contact line (1800 800 110) and local area coordinators.

Family and Carer Support

• Psychoeducation: Parents need clear explanation of the diagnosis, its meaning, and evidence-based supports, challenging the prevalence of non-evidence-based therapies (e.g. facilitated communication, unproven dietary interventions).
• Carer wellbeing: Parental mental health difficulties are common; GP follow-up and carer respite services should be actively facilitated.
• Sibling support: Siblings have elevated risk of developmental difficulties; routine developmental surveillance in siblings is appropriate.
• Relevant Australian organisations: Amaze (Victoria), Autism Spectrum Australia (Aspect), provide information, peer support, and advocacy.

Complications and Special Considerations

Commonly Missed Presentations

• Females: Often present with less obvious restricted/repetitive behaviours and better social masking; may be misdiagnosed with anxiety or eating disorders. Clinical suspicion should be lower threshold in girls.
• Late diagnosis in high-functioning individuals: May present in adolescence with social isolation, depression, anxiety, or school refusal when social demands increase.
• Regression: True regression (loss of milestones) after 12-18 months should prompt urgent evaluation to exclude Rett syndrome, Landau-Kleffner syndrome, and other neurological conditions, including EEG and metabolic workup.

Cultural Considerations and Indigenous Australians

• ASD may be under-recognised or differently interpreted in Aboriginal and Torres Strait Islander communities; cultural concepts of child development and communication may differ.
• Culturally safe and family-centred assessment approaches are essential; interpreter and community liaison services should be engaged.
• NDIS access disparities exist for remote and Indigenous communities, active assistance with navigation is clinically appropriate.

Transition to Adult Services

• NDIS supports continue lifelong but the nature of supports often changes with age.
• Transition planning should begin in early adolescence: educational goals, vocational pathways, and housing considerations.
• Mental health comorbidities (especially anxiety and depression) peak in adolescence and require active monitoring.

Summary: Key Points for Exam and Clinical Practice

• ASD is diagnosed on clinical grounds using DSM-5 criteria (two core domains); ADOS-2 and ADI-R are the gold-standard assessment tools.
• Any developmental regression at any age, or absent pointing/babbling at 12 months, is a red flag requiring urgent referral, do not advise families to "wait and see."
• Chromosomal microarray is recommended for all children with a new ASD diagnosis.
• Early, intensive, naturalistic intervention (20+ hours/week where indicated) improves outcomes; commencement before age 5 is most impactful.
• No medication treats core ASD features; pharmacotherapy targets comorbidities only.
• The NDIS is the primary funding vehicle for intervention in Australia; early access via the Early Childhood Approach does not require a confirmed diagnosis.
• Vaccines do not cause ASD, clinicians must be able to address parental concerns clearly and empathically.

Sources

• eTG Antibiotic section (Therapeutic Guidelines Australia)
• RACGP Red Book, Guidelines for preventive activities in general practice
• Healthdirect Australia clinical information